ISSN: 2475-7640

臨床および実験的移植のジャーナル

オープンアクセス

当社グループは 3,000 以上の世界的なカンファレンスシリーズ 米国、ヨーロッパ、世界中で毎年イベントが開催されます。 1,000 のより科学的な学会からの支援を受けたアジア および 700 以上の オープン アクセスを発行ジャーナルには 50,000 人以上の著名人が掲載されており、科学者が編集委員として名高い

オープンアクセスジャーナルはより多くの読者と引用を獲得
700 ジャーナル 15,000,000 人の読者 各ジャーナルは 25,000 人以上の読者を獲得

抽象的な

Huntington's disease Stem Cell Transplantation?s Potential Therapeutic Application and Pathogenesis

Diana Jacobs

Repetitive CAG or glutamine expression along the Huntington gene’s coding region results in the progressive neurodegenerative disorder known as Huntington’s disease (HD). Certain abnormalities in movement, emotional disturbances, dementia, and cognitive impairments are the effects of this disease. To this date, there could be no legitimate remedy for this uncommon and deadly neurological condition yet there have been sure headways in the field of hereditary creature model examination studies to explain the comprehension of the pathogenesis of this condition. Currently, HD follows a specific therapeutic approach that only treats symptoms and does not address the disease’s underlying cause. Stem cell therapy has the potential to be a game-changer in the search for a cure. The pathogenesis, efficacy, and clinical viability of the therapeutic application of stem cell transplantation in Huntington’s disease have all been discussed in this review. A brief list and analysis of the applications of this revolutionary therapy on genetically modified animal models has been provided.